Abeona Therapeutics Inc.

AI Score

XX

Unlock

4.84
-0.01 (-0.21%)
At close: Apr 17, 2025, 3:59 PM
4.89
1.02%
After-hours: Apr 17, 2025, 07:44 PM EDT

Abeona Therapeutics Statistics

Share Statistics

Abeona Therapeutics has 48.53M shares outstanding. The number of shares has increased by 18.48% in one year.

Shares Outstanding 48.53M
Shares Change (YoY) 18.48%
Shares Change (QoQ) 11.65%
Owned by Institutions (%) 0%
Shares Floating 43.12M
Failed to Deliver (FTD) Shares 2.96K
FTD / Avg. Volume 0.61%

Short Selling Information

The latest short interest is 2.21M, so 4.56% of the outstanding shares have been sold short.

Short Interest 2.21M
Short % of Shares Out 4.56%
Short % of Float 4.78%
Short Ratio (days to cover) 4.2

Valuation Ratios

The PE ratio is -3.59 and the forward PE ratio is -48.35. Abeona Therapeutics's PEG ratio is 0.09.

PE Ratio -3.59
Forward PE -48.35
PS Ratio 0
Forward PS 0.6
PB Ratio 5.19
P/FCF Ratio -3.91
PEG Ratio 0.09
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Abeona Therapeutics.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 6.08, with a Debt / Equity ratio of 0.52.

Current Ratio 6.08
Quick Ratio 6.08
Debt / Equity 0.52
Debt / EBITDA -0.36
Debt / FCF -0.39
Interest Coverage 15.26

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $0
Profits Per Employee $-468.63K
Employee Count 136
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax 0
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by -35.86% in the last 52 weeks. The beta is 1.7, so Abeona Therapeutics's price volatility has been higher than the market average.

Beta 1.7
52-Week Price Change -35.86%
50-Day Moving Average 5.19
200-Day Moving Average 5.55
Relative Strength Index (RSI) 49.29
Average Volume (20 Days) 482.91K

Income Statement

Revenue n/a
Gross Profit 0
Operating Income -64.21M
Net Income -63.73M
EBITDA -64.21M
EBIT -67.94M
Earnings Per Share (EPS) -1.55
Full Income Statement

Balance Sheet

The company has 23.36M in cash and 23.05M in debt, giving a net cash position of 309K.

Cash & Cash Equivalents 23.36M
Total Debt 23.05M
Net Cash 309K
Retained Earnings -813.26M
Total Assets 108.93M
Working Capital 84.27M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -56.02M and capital expenditures -2.45M, giving a free cash flow of -58.46M.

Operating Cash Flow -56.02M
Capital Expenditures -2.45M
Free Cash Flow -58.46M
FCF Per Share -1.42
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

ABEO does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for ABEO is $17, which is 252% higher than the current price. The consensus rating is "Buy".

Price Target $17
Price Target Difference 252%
Analyst Consensus Buy
Analyst Count 4
Stock Forecasts

Stock Splits

The last stock split was on Jul 5, 2022. It was a backward split with a ratio of 1:25.

Last Split Date Jul 5, 2022
Split Type backward
Split Ratio 1:25

Scores

Altman Z-Score -9.09
Piotroski F-Score 2